Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors

Stopped Lack of resources to complete study objectives. No participants enrolled.

Conditions

• Neoplasms

Interventions

• DRUG: Erlotinib
• DRUG: Lenvatinib
• DRUG: Axitinib

Sponsor

National Cancer Institute (NCI)